Theatrical preview for “The Thin Red Line”
Web posted on:
Friday, January 15, 1999 12:19:43 PM EST
From Correspondent Ron Tank
HOLLYWOOD (CNN)- “The Thin Red Line,” director Terrence Malick’s much-anticipated World War II story, showed record-breaking promise in its initial limited release as it debuted last month to a whopping $182,639 in a total of just three theaters in New York and Los Angeles. It’s the best limited-release debut ever for a film, and the trend continued in the New Year, with a box-office take of $1.2 million on just 61 screens last weekend.
Based on the autobiographical novel by James Jones, “The Thin Red Line” tells the story of the men of Company “C”, who fought and died during the fierce battle of Guadalcanal. The story begins as Army troops are moved in to relieve battle-weary. In some cases journalists like to syndicate their own articles.. Some magazines with especially strong resources syndicate their own coverage, including information, to papers outside their own communities. Taking the time to track down and render the most effective posts is not always easy.. A method to cover the very best content can be seen on various news papers that make a team for syndication purposes.As the visitor has the best information to access, provides the greatest importance.Marine units, and follows their journey from the unopposed landing, through the bloody and exhausting battles, to the ultimate departure of the survivors.
The film marks Malick’s return to the director’s chair after a 20-year absence. Malick, who also wrote the screenplay, made two previous pictures, “Badlands” and “Days of Heaven.” For the latter, he received Best Director nods from the New York Film Critics, the National Film Critics and the Cannes Film Festival. ‘An extremely wide mind’
1973’s “Badlands” starred then-unknowns Martin Sheen and Sissy Spacek and even included a cameo appearance by Malick himself. But don’t waste time looking for Malick in his latest film - or in any promotions. His contract with Fox specifies that his likeness not be used to promote the film. To call Malick a recluse would be an understatement. Nolte is also starring in an independent drama, “Affliction,” which hasalready won him a best actor award from the New York FilmCritics
As Nick Nolte says, “he has an extremely wide mind.” In “Line,” Nolte plays Lt. Col. Tall, a career soldier who’s ready to sacrifice his own men for victory in battle. “There’s a little bit of awe you have in Terry, and so it makes you deeply committed to him and the process,” says Nolte.
For this picture, the process started over 10 years ago. In 1988, Malick took his idea of adapting Jones’ novel to producers Robert Michael Geisler and John Roberdeau. They approached the author’s widow, Gloria Jones, and acquired the rights. In September 1996, producer Grant Hill (of “Titanic” fame) came on board, and the film was finally on its way. Big names, small roles
You would think that a big picture would have big-name stars in all the key roles, but quite the opposite is true of this film. The big name stars are there, but their roles are less than stellar. John Travolta is just one of several who take small roles in the film. George Clooney, Sean Penn, John Cusack, and Woody Harrelson all wanted to work for Malick. True to form, the 55-year-old director chose unknowns for most of the key positions.
One of those yet-to-be famous actors, Jim Caviezel, says he’s unsure if he’s prepared for stardom. “I don’t know if you could ever prepare for that,” says Caviezel. “Nick Nolte told me one time, fame is like a red balloon. It just blows up, gets bigger and bigger. It’s just full of hot air.” ALSO:
Review: ‘The Thin Red Line’ a beautiful bomb
Jim Caviezel walking ‘Thin Red Line’ to fame
Twenty years ago, a less famous Travolta was slated to star in Malick’s second film, “Days of Heaven.” Since Travolta was busy making “Grease” at the time, new arrival Richard Gere got the nod. The film was a critical success, taking home an Oscar for cinematography. But the frustration of spending nearly two years editing the film led to Malick’s 20-year hiatus from directing.
Malick also handled the editing duties for “The Thin Red Line,” paring down piles of footage to the final running time of just under three hours. “I think he wants to make an entire different version of it,” says Nolte, “because there are a lot of characters that aren’t followed through.”
And there’s no telling what cinematic treasures ended up on the cutting room floor. Another newcomer in the film, Elias Koteas, says, “I mean, he could be filming one scene, and then while he’s waiting to set this up, he could see something and move another camera and film that for awhile.”
Judging by the reception thus far, Malick appears to have left all the right pieces in place.
The release of Health Information Technology & Privacy comes eight days before the close of the comment period for the Advance Notice of Proposed Rulemaking (ANPRM) of Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators. The proposed changes, which will be highlighted in ACP’s ANPRM comments, are designed to strengthen protections for human research subjects.
"While coming changes did not prompt this paper, its production and release are turning out to be quite timely," noted Virginia L. Hood, MBBS, MPH, FACP, president of ACP. "The paper suggests revisions to the current regulations, which are now being considered because the Department of Health and Human Services (HHS) believes these changes will strengthen protections for research subjects in a number of important ways."
In its 15-page policy paper, ACP proposes 13 policy positions to guide the development of the comprehensive framework. The new policy position, number 4, says:
New Position 4: Regarding research, a revised privacy rule should maximize appropriate uses of information to achieve scientific advances without compromising ethical obligations to protect individual welfare and privacy.
A. Participation in prospective clinical research requires fully informed and transparent consent that discloses all potential uses of PHI and IIHI, and an explanation of any limitations on withdrawing consent for use of data, including biological materials.
B. ACP recognizes that further study is needed to resolve informed consent issues related to future research use of Protected Health Information (PHI) and Individually Identifiable Health Information (IIHI) associated with existing data, including biologic materials.
C. Informed consent documents should clearly disclose whether law enforcement agencies would have access to biobank data without a warrant.
D. ACP recommends that regulations governing IRB review be expanded to include consideration of the preferences of research subjects whose tissue has been stored.
The paper also says that by including providers, governmental bodies, consumers, payers, quality organizations, researchers, and technologists, the resulting framework would clearly specify appropriate activities – such as treatment, payment, and some health care operations – where sharing of personal health information can proceed without the need for additional consent. Once the boundaries of appropriate data-sharing practices and situations are agreed on, it will be far easier to define consent requirements for appropriate activities.
"The patient-doctor relationship is dependent on trust and this extends to the personal information shared as part of that relationship," said Dr. Hood. "As U.S. health care moves from paper to an electronic world, a new national debate over privacy of individually identifiable health information (IIHI) has emerged. Patients need to feel confident that they can receive needed health care without the risk that their private information will be inappropriately disclosed, which might result in withholding of information and lead to potentially negative clinical consequences. Patients benefit when information pertinent to their care, concerns, and preferences is shared among those rendering health care services to them."
ACP strongly believes in the goal of widespread adoption and use of health information technology (HIT) to improve the quality of care, the paper says. ACP supports the concept of safe and secure electronic health information exchange (HIE) and advocates that clinical enterprises, entities, and clinicians wishing to share health information develop principles, procedures, and polices appropriate for the electronic exchange of information necessary to optimize patient care.
The paper emphasizes that privacy policies need to satisfy the growing expectations that the implementation of computerized and networked medical records will facilitate better care at lower overall costs while preserving the expressed intent of one of the principles from the Hippocratic Oath, “All that may come to my knowledge in the exercise of my profession or in daily commerce with men, which ought not to be spread abroad, I will keep secret and will never reveal.”
Provided by American College of Physicians